Search
for
Sort by
Research 661–690 of 1000+
- Depression and anxiety, peripheral blood inflammatory factors, and stress levels on therapeutic outcomes in patients with chronic wounds
- Depression Risk in the Treatment of Moderate to Severe Acne with Isotretinoin
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- PD19-08 MARIJUANA, ALCOHOL, ED AND DEPRESSION: EPIDEMIOLOGIC CORRELATIONS WITH BPH/LUTS
- Depression among adult individuals with androgenic alopecia: A cross-sectional study from the PERSIAN Guilan Cohort Study
- Response to: “finasteride prescribed for hair loss consistently leads to depression”
- Adis Summary of Research: Improvement in measures of quality of life and symptoms of anxiety and depression in patients with severe alopecia areata achieving sustained scalp hair regrowth with baricitinib
- Does hair cortisol mediate the effects of sexual and gender minority stress on depression and anxiety? A structural equation modelling approach
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Prevalence of depression and anxiety and their association with disease activity in patients with systemic lupus erythematosus: A cross-sectional study
- Alopecia Areata and Its Association With Anxiety and Depression: A Case–Control Study in Patients Referred to Dermatology Clinics
- Does hair cortisol mediate the effects of sexual and gender minority stress on depression and anxiety? A structural equation modelling approach
- Depression risk of 5-alpha reductase inhibitors: A systematic review and meta-analysis with a focus on comparator groups
- Finasteride: risk of suicidality and depression
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- Features of the clinical course of the disease, quality of life and systemic cytokine profile in patients with chronic true eczema and depression
- Depression and Anxiety in Patients With Polycystic Ovary Syndrome: A Cross-Sectional Study in Saudi Arabia
- The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH.
- Dermatological Findings in Fibromyalgia Syndrome and Their Effects on Quality of Life, Clinical Findings, and Depression
- Assessment of depression and anxiety in trichodynia patients of Telogen effluvium and Alopecia areata
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Depression from a physical symptom.
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Systematic review: depression, suicidal ideation with finasteride
- Response of Drs. J. E. Pope and E. H. Makela to the Article “Depression Circumstantially Related to the Administration of Finasteride for Androgenetic Alopecia” (J Dermatol, 29, 665-669, 2002): Reply from the Authors of the Questioned Paper
- Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata
- Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia
- Associations between sugar-sweetened beverages consumption, duration of physical exercise, and depressive symptoms among Tibetan university students at high altitude
- Self-Referred Late-Onset Hypogonadism Hypothesis and Testosterone Replacement Therapy in Major Depressive Disorder Under Polypharmacy: A Case Report
- Association of Janus kinase inhibitors with reduced depression in alopecia areata